PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
11-Mar-2025 Global Medical Device Analytical Testing Outsourcing Market to Reach USD 10,867.3 Million by 2034, Driven by Growing Regulatory Compliance Needs | FMI MARKITWIRED
11-Mar-2025 Global Unilateral Biportal Endoscopy Market Poised for Significant Growth, Projected to Reach USD 1,635.1 Million by 2034, Driven by Rising Demand for Minimally Invasive Spinal Surgeries | FMI MARKITWIRED
11-Mar-2025 Global Patient Portal Market to Reach USD 19.08 Billion by 2034, Driven by Digital Health Adoption | FMI MARKITWIRED
11-Mar-2025 Global Motion Stimulation Therapy Market Poised to Reach USD 2 Billion by 2034 Amid Advancements in Therapeutic Technologies | FMI MARKITWIRED
11-Mar-2025 Global Necrotizing Fasciitis Treatment Market Poised for Steady Growth, Projected to Reach USD 4.5 Billion by 2034 | FMI MARKITWIRED
11-Mar-2025 Global Back Therapy Kit Market to Reach USD 6.1 Billion by 2034, Driven by Technological Advancements | FMI MARKITWIRED
11-Mar-2025 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
11-Mar-2025 Curatis Announces Formation of Distinguished Advisory Board Curatis Holding AG
11-Mar-2025 PolyPeptide with substantial improvements in profitability and cash flow, positioned for strong growth PolyPeptide Group
11-Mar-2025 Galenica continues to grow in 2024 Galenica AG
10-Mar-2025 HIV Drugs Industry to Expand from USD 28.6 Billion in 2023 to USD 47.5 Bn by 2034 | States Transparency Market Research, Inc. Transparency Market Research
10-Mar-2025 Lucid Dreaming Devices Market to Reach USD 196.8 Million by 2034, Growing at a 5.1% CAGR – TMR Analysis Transparency Market Research
10-Mar-2025 Syngene Acquires its First Manufacturing Facility in the US defacto communications
10-Mar-2025 Polio Vaccines Market Outlook to Reach USD 1.4 Billion by 2034, Expanding at a 5.0% CAGR – Latest Report by Transparency Market Research Inc Transparency Market Research
10-Mar-2025 Blood Gas and Electrolyte Analyzers Market to Reach USD 5.0 Billion by 2031 – Analysis by TMR Transparency Market Research
10-Mar-2025 Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38 Genmab
10-Mar-2025 AAVantgarde announces 2 presentations at ARVO 2025 annual meeting: LUCE-1 clinical trial data from Usher 1B program & NHP GLP data from Stargardt disease program AAVantgarde Bio
10-Mar-2025 OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain OKYO Pharma
10-Mar-2025 STADA’s growth journey continues in 2024 - Significant increase in sales and profits - Growing ahead of the market STADA
10-Mar-2025 CNX Therapeutics Launches MISABRI PR (Pregabalin) Prolonged-Release Tablets for Neuropathic Pain Management in the UK CNX Therapeutics